| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rivoceranib | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant Neoplasms[MeSHID:D009369] Sarcoma[MeSHID:D012509] |
0.46 | phase 3 | unknown |
| rivoceranib | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Adenocarcinoma[MeSHID:D000230] Malignant Neoplasms[MeSHID:D009369] Sarcoma[MeSHID:D012509] |
0.46 | phase 3 | inhibitor |
| click here to return to the previous page | ||||||||